- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine platforms to control Lassa fever
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 15, Issue 9, Pages 1135-1150
Publisher
Informa UK Limited
Online
2016-05-03
DOI
10.1080/14760584.2016.1184575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses
- (2016) Bjoern Meyer et al. JOURNAL OF VIROLOGY
- Past, present, and future of arenavirus taxonomy
- (2015) Sheli R. Radoshitzky et al. ARCHIVES OF VIROLOGY
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus
- (2015) Kristian G. Andersen et al. CELL
- Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever
- (2015) Jessica N Hartnett et al. Future Virology
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
- (2015) Demetrius Matassov et al. JOURNAL OF INFECTIOUS DISEASES
- A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs
- (2015) Chad E. Mire et al. JOURNAL OF INFECTIOUS DISEASES
- The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity
- (2015) Stephanie Darbre et al. JOURNAL OF VIROLOGY
- General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines
- (2015) Masaharu Iwasaki et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- Unfilled Vials
- (2015) J. Cohen SCIENCE
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever
- (2015) Giovanni Lo Iacono et al. PLoS Neglected Tropical Diseases
- Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
- (2015) Rami Sommerstein et al. PLoS Pathogens
- Widespread Recombination, Reassortment, and Transmission of Unbalanced Compound Viral Genotypes in Natural Arenavirus Infections
- (2015) Mark D. Stenglein et al. PLoS Pathogens
- Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection
- (2014) Ignacio S Caballero et al. BMC GENOMICS
- Absence of CTL Responses to Early Viral Antigens Facilitates Viral Persistence
- (2014) A. Schildknecht et al. JOURNAL OF IMMUNOLOGY
- Delayed Inflammatory and Cell Death Responses Are Associated with Reduced Pathogenicity in Lujo Virus-Infected Cynomolgus Macaques
- (2014) Angela L. Rasmussen et al. JOURNAL OF VIROLOGY
- Lassa Serology in Natural Populations of Rodents and Horizontal Transmission
- (2014) Elisabeth Fichet-Calvet et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Production of CXC and CC Chemokines by Human Antigen-Presenting Cells in Response to Lassa Virus or Closely Related Immunogenic Viruses, and in Cynomolgus Monkeys with Lassa Fever
- (2014) Delphine Pannetier et al. PLoS Neglected Tropical Diseases
- Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression
- (2013) Xue Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of the Live Attenuated Yellow Fever Vaccine 17D-204 Strain to Its Virulent Parental Strain Asibi by Deep Sequencing
- (2013) Andrew Beck et al. JOURNAL OF INFECTIOUS DISEASES
- A Recently Isolated Lassa Virus From Mali Demonstrates Atypical Clinical Disease Manifestations and Decreased Virulence in Cynomolgus Macaques
- (2013) David Safronetz et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic Variation In Vitro and In Vivo of an Attenuated Lassa Vaccine Candidate
- (2013) J. C. Zapata et al. JOURNAL OF VIROLOGY
- Mice Lacking Functional STAT1 Are Highly Susceptible to Lethal Infection with Lassa Virus
- (2013) N. E. Yun et al. JOURNAL OF VIROLOGY
- Infection of Type I Interferon Receptor-Deficient Mice with Various Old World Arenaviruses: A Model for Studying Virulence and Host Species Barriers
- (2013) Toni Rieger et al. PLoS One
- An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
- (2013) Juan C Zapata et al. Virology Journal
- Vaccines for viral hemorrhagic fevers—progress and shortcomings
- (2013) Darryl Falzarano et al. Current Opinion in Virology
- Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali
- (2013) David Safronetz et al. PLoS Neglected Tropical Diseases
- Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure
- (2013) Shikha Malhotra et al. PLoS Neglected Tropical Diseases
- Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
- (2013) Juan Carlos Zapata et al. PLoS Neglected Tropical Diseases
- Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
- (2013) Stephan Ölschläger et al. PLoS Pathogens
- The search for animal models for Lassa fever vaccine development
- (2012) Igor S Lukashevich Expert Review of Vaccines
- Density thresholds for Mopeia virus invasion and persistence in its host Mastomys natalensis
- (2012) J. Goyens et al. JOURNAL OF THEORETICAL BIOLOGY
- Pathogenic Old World Arenaviruses Inhibit TLR2/Mal-Dependent Proinflammatory Cytokines In Vitro
- (2012) M. W. Hayes et al. JOURNAL OF VIROLOGY
- Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever
- (2012) K. G. Andersen et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa
- (2012) Aude Lalis et al. PLoS One
- Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
- (2012) Kathryn M. Hastie et al. PLoS One
- Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model
- (2012) Marco A. Goicochea et al. VACCINE
- Lassa Fever in West Africa: Evidence for an Expanded Region of Endemicity
- (2012) N. Sogoba et al. Zoonoses and Public Health
- Immune Responses and Lassa Virus Infection
- (2012) Marion Russier et al. Viruses-Basel
- Advanced Vaccine Candidates for Lassa Fever
- (2012) Igor Lukashevich Viruses-Basel
- Multifunctional Nature of the Arenavirus RING Finger Protein Z
- (2012) Sarah Fehling et al. Viruses-Basel
- Lymphocytic choriomeningitis virus (LCMV) infection of macaques: A model for Lassa fever
- (2011) Juan C. Zapata et al. ANTIVIRAL RESEARCH
- Argentine hemorrhagic fever vaccines
- (2011) Ana Ambrosio et al. Human vaccines & immunotherapeutics
- Human Dendritic Cells Infected with the Nonpathogenic Mopeia Virus Induce Stronger T-Cell Responses than Those Infected with Lassa Virus
- (2011) D. Pannetier et al. JOURNAL OF VIROLOGY
- Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex
- (2011) P. J. Kranzusch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding
- (2011) K. M. Hastie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies
- (2011) Sebastien E. Emonet et al. VIROLOGY
- Pathogenesis of arenavirus hemorrhagic fevers
- (2010) Marie-Laurence Moraz et al. Expert Review of Anti-Infective Therapy
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
- (2010) Michael A. Whitt JOURNAL OF VIROLOGICAL METHODS
- Rescue from Cloned cDNAs and In Vivo Characterization of Recombinant Pathogenic Romero and Live-Attenuated Candid #1 Strains of Junin Virus, the Causative Agent of Argentine Hemorrhagic Fever Disease
- (2010) S. F. Emonet et al. JOURNAL OF VIROLOGY
- Cap binding and immune evasion revealed by Lassa nucleoprotein structure
- (2010) Xiaoxuan Qi et al. NATURE
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs
- (2010) Xiaohong Jiang et al. VACCINE
- Establishing Efficacy of Human Products Using Animals
- (2010) P. J. Snoy VETERINARY PATHOLOGY
- Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
- (2010) Luis M Branco et al. Virology Journal
- Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys
- (2009) S. Baize et al. JOURNAL OF VIROLOGY
- Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest
- (2009) S. F. Emonet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- Strain-specific antibody response to Lassa virus in the local population of west Africa
- (2008) Petra Emmerich et al. JOURNAL OF CLINICAL VIROLOGY
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
- New opportunities for field research on the pathogenesis and treatment of Lassa fever
- (2007) Sheik Humarr Khan et al. ANTIVIRAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started